查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609115

多重免疫檢測市場：按技術、分析類型、應用和最終用戶 - 2025-2030 年全球預測

Multiplex Detection Immunoassays Market by Technique, Assay Type (Antibody Arrays, Bead-based assay, Blends Protein Arrays ), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，多重檢測免疫檢測市場價值為21.1億美元，預計到2024年將達到22.5億美元，複合年成長率為6.92%，到2030年將達到33.7億美元。

多重免疫檢測是先進的診斷技術，可以同時識別和量化一個樣品中的多種分析物，提高通量，同時降低成本和樣品消費量，從而產生更大的效益。對這些檢測方法的需求是由各個領域的應用推動的，包括臨床診斷、藥物開發、環境測試和食品安全，其中快速和全面的分析至關重要。這些技術的最終用戶包括醫院、研究機構、製藥公司、診斷實驗室等。市場成長的主要驅動力是慢性病和感染疾病的增加、基因組和蛋白質組學研究的進步以及個人化醫療的推動，所有這些都需要創新的診斷工具。最新的潛在機會在於新興市場中多重檢測的廣泛使用及其與數位健康技術的整合，以改善資料管理和患者結果。然而，昂貴的設備、複雜的檢測開發和嚴格的監管要求等因素帶來了重大挑戰。此外，操作複雜的系統需要熟練的人員，這也增加了複雜性。為了克服這些障礙，公司可以投資於旨在簡化檢測設計和操作的創新。潛在的研究和開發領域包括開發更強大的平台以檢測低豐度生物標記物，以及與人工智慧和機器學習整合以增強資料解釋。市場競爭高度分散，領先的公司不斷尋求透過聯盟、研究合作和收購來擴大其產品組合。透過策略性地應對這些挑戰並專注於持續創新和協作，公司可以利用該行業的巨大成長潛力，提高其市場地位，並確保長期成功。

主要市場統計
基準年[2023] 21.1億美元
預計年份 [2024] 22.5億美元
預測年份 [2030] 33.7億美元
複合年成長率（%） 6.92%

市場動態：快速發展的多重免疫檢測市場的關鍵市場洞察

多重檢測免疫檢測市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球慢性病和感染疾病率不斷上升
    • 對個人化精準醫療的偏好日益成長
    • 政府對藥物開發和研究活動提供優惠資助
  • 市場限制因素
    • 設備複雜、高成本
  • 市場機會
    • 醫療保健和製藥業先進技術的出現
    • 臨床診斷自動化設備快速發展
  • 市場挑戰
    • 缺乏技術精湛、經驗豐富的專業人員

開拓波特五力多重免疫檢測市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解多重免疫檢測市場的外部影響

外部宏觀環境因素在塑造多重免疫檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解多重免疫檢測市場的競爭格局

對多重免疫檢測市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣多重免疫檢測市場供應商的績效評估

FPNV定位矩陣是評估多重偵測免疫檢測市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以繪製多重免疫檢測市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，多重免疫檢測市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地慢性病和感染疾病的發生率正在上升
      • 對個人化精準醫療的興趣日益濃厚
      • 政府對藥物開發和研究活動提供優惠資助
    • 抑制因素
      • 相關的設備複雜性和高成本
    • 機會
      • 醫療保健和製藥業先進技術的出現
      • 臨床診斷自動化設備快速發展
    • 任務
      • 缺乏技術精湛、經驗豐富的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章多重檢測免疫檢測市場：依技術分類

  • 基於生物感測器的技術
  • 基於核酸的技術
  • 基於蛋白質的技術

第7章依檢測類型分類的多重檢測免疫檢測市場

  • 抗體陣列
  • 以微珠為基礎的檢測
  • 混合蛋白陣列（多重 ELISA）
  • 以微珠為基礎
  • 非以微珠為基礎
  • 平面分析

第8章多重檢測免疫檢測市場：依應用

  • 疾病檢測
  • 食品污染檢驗
  • 研究與開發
  • 獸醫疾病檢測

第9章多重檢測免疫檢測市場：依最終用戶分類

  • 學術研究所
  • 生技公司
  • 臨床研究組織
  • 診斷中心
  • 食品和飲料公司
  • 製藥公司

第10章美洲多重檢測免疫檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太多重免疫檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲多重免疫檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abcam PLC
  • Advanced Cell Diagnostics, Inc.
  • Aehealth Limited
  • Assay Genie
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories
  • Elabscience Biotechnology Inc.
  • Fortis Life Sciences LLC
  • Illumina Inc.
  • Luminex Corporation by DiaSorin SpA
  • Merck KGaA
  • Meso Scale Diagnostics, LLC
  • PerkinElmer Inc.
  • Promega Corporation
  • Qiagen NV
  • Quansys Biosciences Inc.
  • Quanterix Corporation
  • R&D Systems, Inc.
  • Randox Laboratories Ltd.
  • Sartorius AG
  • Scienion by Bico Company
  • Scorpius BioManufacturing
  • Seegene Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-FF012EDC38B1

The Multiplex Detection Immunoassays Market was valued at USD 2.11 billion in 2023, expected to reach USD 2.25 billion in 2024, and is projected to grow at a CAGR of 6.92%, to USD 3.37 billion by 2030.

Multiplex Detection Immunoassays are advanced diagnostic techniques that allow the simultaneous identification and quantification of multiple analytes in a single sample, offering substantial benefits over traditional assays by increasing throughput while reducing costs and sample consumption. The necessity of these assays is driven by their application across various sectors including clinical diagnostics, drug development, environmental testing, and food safety, where rapid and comprehensive analysis is critical. End-users of these technologies encompass hospitals, research institutions, pharmaceutical companies, and diagnostic laboratories. Market growth is primarily influenced by the increasing prevalence of chronic and infectious diseases, advancements in genomic and proteomic research, and the push for personalized medicine, all demanding innovative diagnostic tools. The latest potential opportunities lie in expanding the use of multiplex assays in emerging markets and integrating them with digital health technologies to improve data management and patient outcomes. However, factors such as the high cost of equipment, complex assay development, and stringent regulatory requirements pose significant challenges. Furthermore, a need for skilled personnel to operate sophisticated systems adds another layer of complexity. To overcome these obstacles, companies can invest in technological innovation aimed at simplifying assay design and operations, which can lower costs and broaden accessibility. Areas of research could include the development of more robust platforms that allow for the detection of low-abundance biomarkers or integration with AI and machine learning for enhanced data interpretation. The market is highly competitive and fragmented, with major players constantly seeking to expand their portfolios through partnerships, collaborations, and acquisitions. By strategically navigating these challenges and focusing on continuous innovation and collaboration, businesses can tap into the significant growth potential in this field, thereby enhancing their market position and ensuring long-term success.

KEY MARKET STATISTICS
Base Year [2023] USD 2.11 billion
Estimated Year [2024] USD 2.25 billion
Forecast Year [2030] USD 3.37 billion
CAGR (%) 6.92%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Multiplex Detection Immunoassays Market

The Multiplex Detection Immunoassays Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of chronic and infectious diseases across the globe
    • Growing preference for personalized -precision medicines
    • Favorable government funding for drug development and research activities
  • Market Restraints
    • Associated complexity and high cost of equipment
  • Market Opportunities
    • Emergence of advanced technologies in the healthcare and pharmaceutical industry
    • Rapid development of automated instruments in clinical diagnostics
  • Market Challenges
    • Dearth of skilled and experienced subject matter experts

Porter's Five Forces: A Strategic Tool for Navigating the Multiplex Detection Immunoassays Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Multiplex Detection Immunoassays Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Multiplex Detection Immunoassays Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Multiplex Detection Immunoassays Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Multiplex Detection Immunoassays Market

A detailed market share analysis in the Multiplex Detection Immunoassays Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Multiplex Detection Immunoassays Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Multiplex Detection Immunoassays Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Multiplex Detection Immunoassays Market

A strategic analysis of the Multiplex Detection Immunoassays Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Multiplex Detection Immunoassays Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Advanced Cell Diagnostics, Inc., Aehealth Limited, Assay Genie, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Charles River Laboratories, Elabscience Biotechnology Inc., Fortis Life Sciences LLC, Illumina Inc., Luminex Corporation by DiaSorin S.p.A., Merck KGaA, Meso Scale Diagnostics, LLC, PerkinElmer Inc., Promega Corporation, Qiagen N.V., Quansys Biosciences Inc., Quanterix Corporation, R&D Systems, Inc., Randox Laboratories Ltd., Sartorius AG, Scienion by Bico Company, Scorpius BioManufacturing, Seegene Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Multiplex Detection Immunoassays Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technique, market is studied across Biosensor-Based Techniques, Nucleic Acid-Based Techniques, and Protein-Based Techniques.
  • Based on Assay Type, market is studied across Antibody Arrays, Bead-based assay, Blends Protein Arrays (Multiplexed ELISA), Magnetic Bead-based, Non-magnetic Bead-based, and Planar Assay.
  • Based on Application, market is studied across Disease Testing, Food Contamination Testing, Research and Development, and Veterinary Disease Testing.
  • Based on End-User, market is studied across Academic Research Institutes, Biotechnology Companies, Clinical Research Organizations, Diagnostic Centers, Food & Beverages Companies, and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of chronic and infectious diseases across the globe
      • 5.1.1.2. Growing preference for personalized -precision medicines
      • 5.1.1.3. Favorable government funding for drug development and research activities
    • 5.1.2. Restraints
      • 5.1.2.1. Associated complexity and high cost of equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of advanced technologies in the healthcare and pharmaceutical industry
      • 5.1.3.2. Rapid development of automated instruments in clinical diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled and experienced subject matter experts
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Multiplex Detection Immunoassays Market, by Technique

  • 6.1. Introduction
  • 6.2. Biosensor-Based Techniques
  • 6.3. Nucleic Acid-Based Techniques
  • 6.4. Protein-Based Techniques

7. Multiplex Detection Immunoassays Market, by Assay Type

  • 7.1. Introduction
  • 7.2. Antibody Arrays
  • 7.3. Bead-based assay
  • 7.4. Blends Protein Arrays (Multiplexed ELISA)
  • 7.5. Magnetic Bead-based
  • 7.6. Non-magnetic Bead-based
  • 7.7. Planar Assay

8. Multiplex Detection Immunoassays Market, by Application

  • 8.1. Introduction
  • 8.2. Disease Testing
  • 8.3. Food Contamination Testing
  • 8.4. Research and Development
  • 8.5. Veterinary Disease Testing

9. Multiplex Detection Immunoassays Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic Research Institutes
  • 9.3. Biotechnology Companies
  • 9.4. Clinical Research Organizations
  • 9.5. Diagnostic Centers
  • 9.6. Food & Beverages Companies
  • 9.7. Pharmaceutical Companies

10. Americas Multiplex Detection Immunoassays Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Multiplex Detection Immunoassays Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Multiplex Detection Immunoassays Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC
  • 2. Advanced Cell Diagnostics, Inc.
  • 3. Aehealth Limited
  • 4. Assay Genie
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Charles River Laboratories
  • 8. Elabscience Biotechnology Inc.
  • 9. Fortis Life Sciences LLC
  • 10. Illumina Inc.
  • 11. Luminex Corporation by DiaSorin S.p.A.
  • 12. Merck KGaA
  • 13. Meso Scale Diagnostics, LLC
  • 14. PerkinElmer Inc.
  • 15. Promega Corporation
  • 16. Qiagen N.V.
  • 17. Quansys Biosciences Inc.
  • 18. Quanterix Corporation
  • 19. R&D Systems, Inc.
  • 20. Randox Laboratories Ltd.
  • 21. Sartorius AG
  • 22. Scienion by Bico Company
  • 23. Scorpius BioManufacturing
  • 24. Seegene Inc.
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. MULTIPLEX DETECTION IMMUNOASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MULTIPLEX DETECTION IMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MULTIPLEX DETECTION IMMUNOASSAYS MARKET DYNAMICS
  • TABLE 7. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BIOSENSOR-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY NUCLEIC ACID-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY PROTEIN-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ANTIBODY ARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BEAD-BASED ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BLENDS PROTEIN ARRAYS (MULTIPLEXED ELISA), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY MAGNETIC BEAD-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY NON-MAGNETIC BEAD-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY PLANAR ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY FOOD CONTAMINATION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY VETERINARY DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY FOOD & BEVERAGES COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 199. MULTIPLEX DETECTION IMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023